Fusen Pharmaceutical Company Limited (1652.HK)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2026-04-07 2025-06-30 2025-03-31 2024-12-31
Revenue 111,286,000 111,286,000 55,643,000 64,853,500
Cost of Revenue 68,296,000 68,296,000 34,148,000 36,471,000
Gross Profit 42,990,000 42,990,000 21,495,000 28,382,500
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 45,331,000 45,331,000 22,665,500 26,425,500
Operating Expenses 63,184,000 63,184,000 31,592,000 43,868,500
Operating Income -20,194,000 -20,194,000 -10,097,000 -15,486,000
Interest Expense 0 7,816,000 0 0
Income Before Tax -22,725,000 -22,725,000 -11,362,500 -72,560,500
Income Tax Expense 411,000 411,000 205,500 3,365,000
Net Income -23,136,000 -23,136,000 -11,568,000 -75,921,000
Per Share
EPS -0.03 -0.03 -0.02 -0.10
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 326,029,000 565,608,000 491,757,000 385,664,000 486,854,000
Cost of Revenue 163,392,000 266,102,000 266,736,000 174,531,000 220,787,000
Gross Profit 162,637,000 299,506,000 225,021,000 211,133,000 266,067,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 141,283,000 214,439,000 188,642,000 156,181,000 186,281,000
Operating Expenses 230,148,000 279,490,000 186,414,000 146,646,000 181,830,000
Operating Income -67,511,000 20,016,000 15,738,000 52,137,000 84,237,000
Interest Expense 0 12,583,000 12,382,000 9,655,000 9,434,000
Income Before Tax -190,446,000 -29,448,000 -30,993,000 23,791,000 78,405,000
Income Tax Expense 1,646,000 6,847,000 3,661,000 7,178,000 15,737,000
Net Income -188,783,000 -36,277,000 -34,654,000 16,645,000 70,131,000
Per Share
EPS -0.26 -0.05 -0.05 0.02 0.09
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 21,056,000 34,849,000 128,106,000 81,063,000
Short Term Investments 0 0 4,595,000 642,000
Net Receivables 113,878,000 183,482,000 247,189,000 0
Inventory 137,082,000 184,199,000 110,649,000 121,845,000
Total Current Assets 459,612,000 566,802,000 614,056,000 509,222,000
Property Plant Equipment 621,330,000 562,182,000 314,370,000 506,034,000
Goodwill and Intangibles 28,135,000 22,551,000 215,858,000 0
Total Assets 1,238,161,000 1,343,745,000 1,350,268,000 1,239,336,000
Liabilities
Account Payables 123,466,000 167,545,000 163,613,000 102,115,000
Short Term Debt 304,464,000 237,643,000 227,949,000 162,748,000
Total Current Liabilities 772,445,000 664,520,000 722,082,000 489,266,000
Long Term Debt 79,230,000 106,472,000 432,000 77,940,000
Total Liabilities 869,799,000 781,519,000 737,375,000 582,392,000
Shareholders Equity
Retained Earnings 0 292,607,000 274,813,000 0
Total Shareholders Equity 369,671,000 563,518,000 614,167,000 658,169,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 21,056,000 34,849,000 128,106,000 81,063,000 297,038,000
Short Term Investments 0 0 4,595,000 642,000 15,489,000
Net Receivables 113,878,000 183,482,000 247,189,000 0 0
Inventory 137,082,000 184,199,000 110,649,000 121,845,000 105,415,000
Total Current Assets 459,612,000 566,802,000 614,056,000 509,222,000 660,367,000
Property Plant Equipment 621,330,000 562,182,000 314,370,000 506,034,000 238,002,000
Goodwill and Intangibles 28,135,000 22,551,000 215,858,000 0 248,809,000
Total Assets 1,238,161,000 1,343,745,000 1,350,268,000 1,239,336,000 1,241,347,000
Liabilities
Account Payables 123,466,000 167,545,000 163,613,000 102,115,000 108,585,000
Short Term Debt 304,464,000 237,643,000 227,949,000 162,748,000 178,500,000
Total Current Liabilities 772,445,000 664,520,000 722,082,000 489,266,000 547,606,000
Long Term Debt 79,230,000 106,472,000 432,000 77,940,000 20,000,000
Total Liabilities 869,799,000 781,519,000 737,375,000 582,392,000 583,098,000
Shareholders Equity
Retained Earnings 0 292,607,000 274,813,000 0 0
Total Shareholders Equity 369,671,000 563,518,000 614,167,000 658,169,000 658,249,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income -190,446,000 -29,448,000 -30,993,000 16,645,000
Depreciation & Amortization 41,711,000 35,798,000 34,161,000 23,785,000
Stock Based Compensation 805,000 1,453,000 1,153,000 0
Change in Working Capital 150,503,000 -80,489,000 38,407,000 -30,591,000
Operating Cash Flow 133,730,000 -73,334,000 110,490,000 47,766,000
Investing Activities
Capital Expenditure -76,298,000 -88,511,000 -23,862,000 -110,133,000
Investments -60,959,000 -66,241,000 -23,862,000 -110,133,000
Investing Cash Flow -163,423,000 -108,318,000 -13,131,000 -282,977,000
Financing Activities
Debt Repayment 41,663,000 119,730,000 -306,527,000 -245,569,000
Common Stock Issued/Repurchased -6,464,000 -15,988,000 -10,073,000 -7,390,000
Dividends Paid 0 0 -6,959,000 -8,306,000
Financing Cash Flow 15,994,000 88,503,000 -51,766,000 20,527,000
Summary
Free Cash Flow 57,432,000 -161,845,000 86,628,000 -62,367,000
Net Change in Cash -13,793,000 -93,257,000 47,043,000 -215,975,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income -190,446,000 -29,448,000 -30,993,000 16,645,000 70,131,000
Depreciation & Amortization 41,711,000 35,798,000 34,161,000 23,785,000 22,457,000
Stock Based Compensation 805,000 1,453,000 1,153,000 0 17,632,000
Change in Working Capital 150,503,000 -80,489,000 38,407,000 -30,591,000 44,243,000
Operating Cash Flow 133,730,000 -73,334,000 110,490,000 47,766,000 153,207,000
Investing Activities
Capital Expenditure -76,298,000 -88,511,000 -23,862,000 -110,133,000 -58,645,000
Investments -60,959,000 -66,241,000 -23,862,000 -110,133,000 -58,645,000
Investing Cash Flow -163,423,000 -108,318,000 -13,131,000 -282,977,000 -68,197,000
Financing Activities
Debt Repayment 41,663,000 119,730,000 -306,527,000 -245,569,000 -220,000,000
Common Stock Issued/Repurchased -6,464,000 -15,988,000 -10,073,000 -7,390,000 -94,793,000
Dividends Paid 0 0 -6,959,000 -8,306,000 -3,145,000
Financing Cash Flow 15,994,000 88,503,000 -51,766,000 20,527,000 -116,330,000
Summary
Free Cash Flow 57,432,000 -161,845,000 86,628,000 -62,367,000 94,562,000
Net Change in Cash -13,793,000 -93,257,000 47,043,000 -215,975,000 -34,006,000